{"code":"G21.19","type":"code","title":"Other drug induced secondary parkinsonism","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["Huntington's disease (G10)","neurocognitive disorder with Lewy bodies (G31.83)","Shy-Drager syndrome (G90.3)","syphilitic Parkinsonism (A52.19)"],"excludes2":[],"isBillable":true,"inclusionTerms":["Other medication-induced parkinsonism"],"useAdditionalCode":["code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)"],"clinicalDefinition":"Other drug induced secondary parkinsonism is a billable ICD-10-CM diagnosis code (G21.19). Inclusion terms: Other medication-induced parkinsonism. Excludes1 (not coded here): Huntington's disease (G10); neurocognitive disorder with Lewy bodies (G31.83); Shy-Drager syndrome (G90.3); syphilitic Parkinsonism (A52.19). Use additional code: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).","officialDefinition":"Other drug induced secondary parkinsonism is a billable ICD-10-CM diagnosis code (G21.19). Inclusion terms: Other medication-induced parkinsonism. Excludes1 (not coded here): Huntington's disease (G10); neurocognitive disorder with Lewy bodies (G31.83); Shy-Drager syndrome (G90.3); syphilitic Parkinsonism (A52.19). Use additional code: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}